从LncRNA到转移:癌症进展中的MALAT1-EMT轴
Riya Thapa1, Obaid Afzal2, Muhammad Afzal3
1School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, Jaipur, India.
Pathology, research and practice
|November 29, 2023
概括
转移相关的肺腺癌转录1 (MALAT1) 通过控制表皮-介质细胞转换 (EMT) 过程,驱动癌症转移. 针对MALAT1提供了潜在的治疗策略,以减少癌症的传播和改善患者的治疗结果.
科学领域:
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 癌症转移是死亡的主要原因.
- 长非编码RNAs (LncRNAs) 在癌症进展中起着关键作用.
- 转移相关的肺腺癌转录1 (MALAT1) 涉及到转移.
研究的目的:
- 研究MALAT1在癌症转移中的作用.
- 阐明MALAT1通过表皮层-介质细胞转变 (EMT) 促进转移的机制.
- 探索针对MALAT1-EMT轴的治疗策略.
主要方法:
- 分析涉及MALAT1,转录因子和信号通路的调节网络.
- 检查MALAT1对EMT效应器基因表达的影响 (例如N-cadherin,E-cadherin,Snail).
- 对MALAT1和EMT的现有文献和机制研究的审查.
主要成果:
- 通过调节EMT过程,MALAT1显著促进癌症转移.
- 马拉特1影响EMT关键标记物的表达,导致瘤细胞的攻击性.
- 该研究确定了一个由MALAT1.1协调的复杂的监管网络.
结论:
- MALAT1-EMT轴是癌症转移的一个关键决定因素.
- 准MALAT1或其下游效应器是一个有前途的治疗途径.
- 了解这一轴可以带来新的策略来缓解转移,并改善患者的预后.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K


